Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Genistin is an isoflavone glycoside predominantly found in soy products. There is some scientific evidence, primarily from animal studies and a limited number of human studies, suggesting that genistin and its aglycone form, genistein, may have beneficial effects on lipid metabolism, including the reduction of serum triglycerides. The proposed mechanism involves modulation of lipid metabolic enzymes, improvement in insulin sensitivity, and potential regulation of gene expression related to lipid metabolism. For example, some rodent studies have shown that soy isoflavone supplementation can lower plasma triglyceride levels, potentially due to the inhibition of hepatic fatty acid synthesis and enhanced fatty acid oxidation. Furthermore, a few small-scale human clinical trials with soy isoflavones (which include genistin among other compounds) have demonstrated modest reductions in triglycerides, though results have been inconsistent and the specific contribution of genistin itself remains unclear.

Despite these findings, the overall quality and quantity of evidence is limited. Most human studies use mixed isoflavone preparations, making it difficult to isolate the effects of genistin. Moreover, larger, well-controlled clinical trials are necessary to confirm efficacy and establish optimal dosing. As such, while there is preliminary scientific support for genistin’s role in triglyceride management, the evidence is not robust. Therefore, the current scientific validation for genistin’s use in treating high triglycerides is weak to moderate, warranting a rating of 2 out of 5.

More about genistin
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by genistin

Products containing genistin

Metagenics Testralin®